BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 33009287)

  • 1. Development of a High-Throughput Quantification Method for Pazopanib Using Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry and Its Clinical Application in Patients With Soft Tissue Tumors.
    Shiraiwa K; Suzuki Y; Tanaka K; Kawano M; Iwasaki T; Matsumoto A; Tanaka R; Tatsuta R; Tsumura H; Itoh H
    Ther Drug Monit; 2021 Jun; 43(3):416-421. PubMed ID: 33009287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitive quantification of free pazopanib using ultra-high performance liquid chromatography coupled to tandem mass spectrometry and assessment of clinical application.
    Matsumoto A; Shiraiwa K; Suzuki Y; Tanaka K; Kawano M; Iwasaki T; Tanaka R; Tatsuta R; Tsumura H; Itoh H
    J Pharm Biomed Anal; 2021 Nov; 206():114348. PubMed ID: 34509660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of an HPLC-UV method for pazopanib quantification in human plasma and application to patients with cancer in routine clinical practice.
    Escudero-Ortiz V; Pérez-Ruixo JJ; Valenzuela B
    Ther Drug Monit; 2015 Apr; 37(2):172-9. PubMed ID: 25072946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous monitoring of pazopanib and its metabolites by UPLC-MS/MS.
    Paludetto MN; Puisset F; Le Louedec F; Allal B; Lafont T; Chatelut E; Arellano C
    J Pharm Biomed Anal; 2018 May; 154():373-383. PubMed ID: 29571135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Broad Range High-Throughput Assay for Lenvatinib Using Ultra-High Performance Liquid Chromatography Coupled to Tandem Mass Spectrometry With Clinical Application in Patients With Hepatocellular Carcinoma.
    Sueshige Y; Shiraiwa K; Honda K; Tanaka R; Saito T; Tokoro M; Iwao M; Endo M; Arakawa M; Tatsuta R; Seike M; Murakami K; Itoh H
    Ther Drug Monit; 2021 Oct; 43(5):664-671. PubMed ID: 34521802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of pazopanib (GW-786034) in mouse plasma and brain tissue by liquid chromatography-tandem mass spectrometry (LC/MS-MS).
    Minocha M; Khurana V; Mitra AK
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Jul; 901():85-92. PubMed ID: 22749591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-throughput and wide-range simultaneous determination of linezolid, daptomycin and tedizolid in human plasma using ultra-performance liquid chromatography coupled to tandem mass spectrometry.
    Tanaka R; Kai M; Goto K; Ohchi Y; Yasuda N; Tatsuta R; Kitano T; Itoh H
    J Pharm Biomed Anal; 2021 Feb; 194():113764. PubMed ID: 33298382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fast and Straightforward Method for the Quantification of Pazopanib in Human Plasma Using LC-MS/MS.
    Verheijen RB; Thijssen B; Rosing H; Schellens JHM; Nan L; Venekamp N; Beijnen JH; Steeghs N; Huitema ADR
    Ther Drug Monit; 2018 Apr; 40(2):230-236. PubMed ID: 29256969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of the next-generation oral anti-tumor drugs dabrafenib, trametinib, vemurafenib, cobimetinib, pazopanib, regorafenib and two metabolites in human plasma by liquid chromatography-tandem mass spectrometry.
    Cardoso E; Mercier T; Wagner AD; Homicsko K; Michielin O; Ellefsen-Lavoie K; Cagnon L; Diezi M; Buclin T; Widmer N; Csajka C; Decosterd L
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Apr; 1083():124-136. PubMed ID: 29544202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and clinical validation of an LC-MS/MS method for the quantification of pazopanib in DBS.
    Verheijen RB; Bins S; Thijssen B; Rosing H; Nan L; Schellens JH; Mathijssen RH; Lolkema MP; Beijnen JH; Steeghs N; Huitema AD
    Bioanalysis; 2016; 8(2):123-34. PubMed ID: 26652864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-Sensitivity and High-Throughput Quantification of Everolimus in Human Whole Blood Using Ultrahigh-Performance Liquid Chromatography Coupled With Tandem Mass Spectrometry.
    Miyagi C; Tanaka R; Hirata K; Watanabe T; Tatsuta R; Miyamura S; Itoh H
    Ther Drug Monit; 2022 Oct; 44(5):633-640. PubMed ID: 35383726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-throughput simultaneousquantification offive azole anti-fungal agents and one active metabolite in human plasma using ultra-high-performance liquid chromatography coupled to tandem mass spectrometry.
    Tanaka R; Shiraiwa K; Takano K; Ogata M; Honda S; Yoshida N; Okuhiro K; Yoshida M; Narahara K; Kai M; Tatsuta R; Itoh H
    Clin Biochem; 2022 Jan; 99():87-96. PubMed ID: 34715112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and Validation of a Simultaneous Quantification Method of Ruxolitinib, Vismodegib, Olaparib, and Pazopanib in Human Plasma Using Liquid Chromatography Coupled With Tandem Mass Spectrometry.
    Pressiat C; Huynh HH; Plé A; Sauvageon H; Madelaine I; Chougnet C; Le Maignan C; Mourah S; Goldwirt L
    Ther Drug Monit; 2018 Jun; 40(3):337-343. PubMed ID: 29474275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of sensitive and selective quantification of total and free daptomycin in human plasma using ultra-performance liquid chromatography coupled to tandem mass spectrometry.
    Tanaka R; Suzuki Y; Goto K; Yasuda N; Koga H; Kai S; Ohchi Y; Sato Y; Kitano T; Itoh H
    J Pharm Biomed Anal; 2019 Feb; 165():56-64. PubMed ID: 30502552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous quantification method for 5-FU, uracil, and tegafur using UPLC-MS/MS and clinical application in monitoring UFT/LV combination therapy after hepatectomy.
    Shiraiwa K; Suzuki Y; Uchida H; Iwashita Y; Tanaka R; Iwao M; Tada K; Hirashita T; Masuda T; Endo Y; Inomata M; Itoh H
    Sci Rep; 2021 Feb; 11(1):3132. PubMed ID: 33542452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of a high-performance liquid chromatography-tandem mass spectrometry assay quantifying vemurafenib in human plasma.
    Nijenhuis CM; Rosing H; Schellens JH; Beijnen JH
    J Pharm Biomed Anal; 2014 Jan; 88():630-5. PubMed ID: 24216282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High throughput identification and quantification of 16 antipsychotics and 8 major metabolites in serum using ultra-high performance liquid chromatography-tandem mass spectrometry.
    Patteet L; Maudens KE; Sabbe B; Morrens M; De Doncker M; Neels H
    Clin Chim Acta; 2014 Feb; 429():51-8. PubMed ID: 24291056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel, rapid and sensitive UPLC-MS/MS method for the determination of macitentan in patients with pulmonary arterial hypertension.
    Albayrak M; Atıla A; Yılmazel Ucar E; Araz O; Kadıoglu Y
    Biomed Chromatogr; 2019 May; 33(5):e4502. PubMed ID: 30725476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous determination of rosuvastatin and fenofibric acid in human plasma by LC-MS/MS with electrospray ionization: assay development, validation and application to a clinical study.
    Trivedi RK; Kallem RR; Mullangi R; Srinivas NR
    J Pharm Biomed Anal; 2005 Sep; 39(3-4):661-9. PubMed ID: 15970417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification and pharmacokinetic study of entrectinib in rat plasma using ultra-performance liquid chromatography tandem mass spectrometry.
    Wang Q; Fang P; Zheng L; Ye L
    Biomed Chromatogr; 2019 Apr; 33(4):e4467. PubMed ID: 30549079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.